HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

P Vidailhet Selected Research

Antipsychotic Agents (Antipsychotics)

1/2021Recommendations of the schizophrenia expert center network for the screening prevention and treatment of sleep disorders based on the results from the real-world schizophrenia FACE-SZ national cohort.
1/2020Confirmations, advances and recommendations for the daily care of schizophrenia based on the French national FACE-SZ cohort.
12/2019Chronic low-grade peripheral inflammation is associated with ultra resistant schizophrenia. Results from the FACE-SZ cohort.
6/2019Tobacco smoking is associated with antipsychotic medication, physical aggressiveness, and alcohol use disorder in schizophrenia: results from the FACE-SZ national cohort.
2/2019[The 10-year findings from the FondaMental Academic Center of Expertise for Schizophrenia (FACE-SZ): Review and recommendations for clinical practice].
12/2015Akathisia: prevalence and risk factors in a community-dwelling sample of patients with schizophrenia. Results from the FACE-SZ dataset.
2/2012[RÉALITÉ LT, a pharmacoepidemiological study of semiology and therapeutic strategy of patients with schizophrenia treated by antipsychotic loxapine in routine clinical practice].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


P Vidailhet Research Topics

Disease

10Schizophrenia (Dementia Praecox)
12/2019 - 02/2012
6Inflammation (Inflammations)
12/2019 - 08/2017
4Psychomotor Agitation (Akathisia)
01/2021 - 12/2015
4Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2020 - 12/2018
2Major Depressive Disorder (Major Depressive Disorders)
02/2019 - 01/2019
1Migraine Disorders (Migraine)
01/2021
1Sleep Wake Disorders
01/2021
1Critical Illness (Critically Ill)
06/2020
1Psychotic Disorders (Schizoaffective Disorder)
01/2020
1Parkinsonian Disorders (Parkinsonism)
01/2020
1Alcoholism (Alcohol Abuse)
06/2019
1Weight Gain
02/2019
1Anxiety Disorders (Anxiety Disorder)
12/2018
1Neurobehavioral Manifestations
12/2018
1Infections
11/2018
1Overweight
09/2018
1Cognitive Dysfunction
08/2017
1Substance-Related Disorders (Drug Abuse)
12/2015
1Amnesia (Dissociative Amnesia)
07/2000

Drug/Important Bio-Agent (IBA)

7Antipsychotic Agents (Antipsychotics)IBA
01/2021 - 02/2012
4BenzodiazepinesIBA
01/2020 - 07/2000
3C-Reactive ProteinIBA
12/2019 - 09/2018
2Antidepressive Agents (Antidepressants)IBA
12/2019 - 12/2015
2Cholinergic Antagonists (Anticholinergics)IBA
01/2019 - 12/2015
1Clozapine (Clozaril)FDA LinkGeneric
01/2020
1Pharmaceutical PreparationsIBA
01/2020
1Untranslated Regions (Untranslated Region)IBA
12/2019
1Olanzapine (Zyprexa)FDA Link
01/2019
1Biological ProductsIBA
12/2018
1Vitamin DFDA LinkGeneric
12/2018
1N-Methylaspartate (NMDA)IBA
11/2018
1Dopamine (Intropin)FDA LinkGeneric
11/2018
1cyamemazineIBA
09/2018
1Clomipramine (Anafranil)FDA LinkGeneric
09/2018
1dipropylacetamide (valpromide)IBA
09/2018
1Hypnotics and Sedatives (Sedatives)IBA
09/2018
1Valproic Acid (Depakote)FDA LinkGeneric
09/2018
1Quetiapine Fumarate (Seroquel)FDA Link
09/2018
1Aripiprazole (Abilify)FDA Link
09/2018
1Psychotropic Drugs (Psychoactive Drugs)IBA
09/2018
1cyclopropapyrroloindoleIBA
08/2017
1Loxapine (Loxitane)FDA LinkGeneric
02/2012

Therapy/Procedure

2Therapeutics
08/2019 - 01/2019
1Mechanical Ventilators (Ventilator)
06/2020
1Aftercare (After-Treatment)
02/2019
1Precision Medicine
01/2019